|  |  | BCCAO/R | BCP treatment | BCP treatment x BCCAO/R |  | |||
---|---|---|---|---|---|---|---|---|---|
 | Marker | F value | p value | F value | p value | F value | p value | DF | |
Frontal cortex | HPLC-MS | AEA | 4.152 | 0.0482 | 10.82 | 0.0021 | 2.279 | ns | 1, 40 |
2-AG | 1.804 | ns | 0.4065 | ns | 6.427 | 0.0153 | 1, 40 | ||
PEA | 0.4636 | ns | 12.29 | 0.0012 | 19.34 | < 0.0001 | 1, 40 | ||
OEA | 0.0017 | ns | 18.19 | 0.0001 | 3.7 | 0.0615 | 1, 40 | ||
DHA | 6.972 | 0.0118 | 4.826 | 0.0339 | 3.205 | 0.0810 | 1, 40 | ||
Lipoperoxides | 5.665 | 0.0223 | 12.33 | 0.0011 | 4,580 | 0.0387 | 1, 39 | ||
Western blot | CB1 receptor | 16.83 | 0.0002 | 14.53 | 0.0004 | 0.0136 | ns | 1, 44 | |
CB2 receptor | 15.05 | 0.0004 | 0.0396 | ns | 4.51 | 0.0401 | 1, 39 | ||
PPAR-alpha | 12.29 | 0.0011 | 39.66 | < 0.0001 | 6.264 | 0.0163 | 1, 42 | ||
COX-2 | 0.1578 | ns | 0.05464 | ns | 5.088 | 0.0299 | 1, 38 | ||
Plasma | HPLC-MS | AEA | 11.78 | 0.0014 | 44.16 | <0.0001 | 0.824 | ns | 1, 40 |
2-AG | 7.081 | 0.0112 | 1.907 | ns | 0.0916 | ns | 1, 40 | ||
PEA | 1.034 | ns | 4.605 | 0.0380 | 2.119 | ns | 1, 40 | ||
OEA | 0.7309 | ns | 2.321 | 0.1355 | 0.4911 | ns | 1, 40 | ||
DHA | 1.034 | ns | 4.605 | 0.0380 | 2.119 | ns | 1, 40 | ||
Lipoperoxides | 5.879 | 0.0199 | 7.68 | 0.0084 | 2.547 | ns | 1, 40 |